Sanjay Kumar Gupta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sanjay Kumar Gupta has a total of 106 co-authors. Here are the top co-authors by number of shared publications:
Akash Gupta
13 shared publications- Akash Gupta
Department of Pharmacology, Rungta College of Pharmaceutical Sciences and Research, School of Pharmacy, Rungta International Skills University, Bhilai, Durg, Chhattisgarh, 490024, India
8 shared publications Ajazuddin
7 shared publicationsSumit Sahu
6 shared publicationsKamal Shah
5 shared publicationsNagendra Singh Chauhan
5 shared publications
Latest Publications
- Open Access
- 20 October 2026
- Published by Elsevier in Pharmacological Research - Modern Chinese Medicine
- Vol. 21
Impact of polyherbal formulation on cognitive functions in a scopolamine-induced cognitive impairment model: a spatial memory and learning perspective
- 20 October 2026
- Published by Elsevier in Pharmacological Research - Modern Chinese Medicine
- Vol. 21
Open AccessImpact of polyherbal formulation on cognitive functions in a scopolamine-induced cognitive impairment model: a spatial memory and learning perspective
- 16 October 2026
- Published by Taylor & Francis
- p. 243-256
Therapeutic Potential of Mangrove-Derived Bioactive Compounds in Respiratory Disease Management
Mangrove ecosystems possess unique biodiversity and environmental resilience, containing a wealth of bioactive compounds with potentially high pharmacological activity. Recent studies have demonstrated the therapeutic potential of active metabolites of mangrove origin, including alkaloids, flavonoids, terpenoids, and polyphenols, in the treatment of respiratory diseases, such as bronchial asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and respiratory infections. Evidence of anti-inflammatory, antioxidant, antimicrobial, and immunomodulatory activities of these compounds may be important in mitigating the pathophysiological mechanisms of respiratory disorders. This chapter mentions present-day knowledge regarding bioactive components derived from mangroves, the ways these materials move, and how they can be utilized for the production of respiratory therapeutics. An attempt has been made to combine traditional medicine and current pharmacological studies to create new plant-derived respiratory treatments that are free from synthetic chemicals. Additional clinical research, as well as bioavailability studies, are required to implement new plant-based respiratory therapies into practice.
- 16 October 2026
- Published by Taylor & Francis
- p. 243-256
Therapeutic Potential of Mangrove-Derived Bioactive Compounds in Respiratory Disease Management
Mangrove ecosystems possess unique biodiversity and environmental resilience, containing a wealth of bioactive compounds with potentially high pharmacological activity. Recent studies have demonstrated the therapeutic potential of active metabolites of mangrove origin, including alkaloids, flavonoids, terpenoids, and polyphenols, in the treatment of respiratory diseases, such as bronchial asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and respiratory infections. Evidence of anti-inflammatory, antioxidant, antimicrobial, and immunomodulatory activities of these compounds may be important in mitigating the pathophysiological mechanisms of respiratory disorders. This chapter mentions present-day knowledge regarding bioactive components derived from mangroves, the ways these materials move, and how they can be utilized for the production of respiratory therapeutics. An attempt has been made to combine traditional medicine and current pharmacological studies to create new plant-derived respiratory treatments that are free from synthetic chemicals. Additional clinical research, as well as bioavailability studies, are required to implement new plant-based respiratory therapies into practice.
- 16 October 2026
- Published by Taylor & Francis
- p. 227-240
Mangroves as a Source of Polyphenols
Mangrove ecosystems, long valued for their ecological role in protecting coastlines and supporting biodiversity, are increasingly recognized as rich sources of bioactive compounds. Among these, polyphenols have attracted significant attention due to their structural diversity and broad pharmacological potential. This review explores the phytochemical diversity of mangroves, with particular focus on the distribution of polyphenols across species and the environmental factors that shape their content. Extraction methods, including conventional solvent techniques and modern approaches such as ultrasound, microwave-assisted, and green technologies, are discussed alongside analytical tools such as high-performance liquid chromatography-mass spectrometry (LC-MS), and nuclear magnetic resonance that aid in their characterization. The biological activities of mangrove-derived polyphenols are wide-ranging, encompassing antioxidant, anti-inflammatory, antimicrobial, antiviral, and anticancer effects, which underpin their therapeutic promise. Their integration into traditional medicine, as well as emerging applications in food preservation, skincare, and nutraceuticals, further highlights their versatility. Advances in biotechnology, particularly tissue culture and metabolic engineering, provide alternative pathways for scalable polyphenol production without compromising natural ecosystems.
- 16 October 2026
- Published by Taylor & Francis
- p. 227-240
Mangroves as a Source of Polyphenols
Mangrove ecosystems, long valued for their ecological role in protecting coastlines and supporting biodiversity, are increasingly recognized as rich sources of bioactive compounds. Among these, polyphenols have attracted significant attention due to their structural diversity and broad pharmacological potential. This review explores the phytochemical diversity of mangroves, with particular focus on the distribution of polyphenols across species and the environmental factors that shape their content. Extraction methods, including conventional solvent techniques and modern approaches such as ultrasound, microwave-assisted, and green technologies, are discussed alongside analytical tools such as high-performance liquid chromatography-mass spectrometry (LC-MS), and nuclear magnetic resonance that aid in their characterization. The biological activities of mangrove-derived polyphenols are wide-ranging, encompassing antioxidant, anti-inflammatory, antimicrobial, antiviral, and anticancer effects, which underpin their therapeutic promise. Their integration into traditional medicine, as well as emerging applications in food preservation, skincare, and nutraceuticals, further highlights their versatility. Advances in biotechnology, particularly tissue culture and metabolic engineering, provide alternative pathways for scalable polyphenol production without compromising natural ecosystems.
- 16 October 2026
- Published by Taylor & Francis
- p. 214-226
Mangroves as a Source for Saponins
Mangrove ecosystems, which are found at the land-sea interface in tropical and subtropical regions, are an important source of bioactive substances, especially saponins, a natural glycoside pharmacologically important. In this review, we explore the botanical aspects of mangroves, the structure and classification of saponins, and progress made on extraction and analytical techniques. The article briefly highlights high-yielding mangrove species and examines the effects of geographic and seasonal variation on saponin content, as well as recent research detailing species-delimited saponin profiles. The future directions of the field include synthetic biology, metabolic engineering, newer delivery systems, and collaborative research projects to maximize the potential of mangrove saponins. This review has provided an important cross-disciplinary resource by filling in the knowledge gap and providing guidance for the sustainable development and industrial commercialization of saponins derived from mangrove habitats.
- 16 October 2026
- Published by Taylor & Francis
- p. 214-226
Mangroves as a Source for Saponins
Mangrove ecosystems, which are found at the land-sea interface in tropical and subtropical regions, are an important source of bioactive substances, especially saponins, a natural glycoside pharmacologically important. In this review, we explore the botanical aspects of mangroves, the structure and classification of saponins, and progress made on extraction and analytical techniques. The article briefly highlights high-yielding mangrove species and examines the effects of geographic and seasonal variation on saponin content, as well as recent research detailing species-delimited saponin profiles. The future directions of the field include synthetic biology, metabolic engineering, newer delivery systems, and collaborative research projects to maximize the potential of mangrove saponins. This review has provided an important cross-disciplinary resource by filling in the knowledge gap and providing guidance for the sustainable development and industrial commercialization of saponins derived from mangrove habitats.
- 16 October 2026
- Published by Taylor & Francis
- p. 197-213
Mangroves as a Source for Tannins
Mangroves are special coastal ecosystems that are very important sources of natural tannins, natural polyphenolic substances with pharmacological, industrial, or environmental applications. This review examines the diversity of mangrove species that produce tannins, the chemical structures and classification of tannins, and their applications. Mangrove tannins have potent antimicrobial, antioxidant, and anti-inflammatory properties, which may serve therapeutic uses and several biotechnological applications, including drug delivery systems and biodegradable materials. Industrial uses include leather tanning, dyeing, and preservation, reflecting their diverse commercial applications. Conservation and harvesting of mangrove resources need to be considered, as over-exploitation of these resources can have negative impacts on mangrove community health, biodiversity, and ecosystem services. This review will include traditional and modern harvesting practices, analyses and analytical technologies, and other variables that may influence the production and quality of tannins. The review will illustrate potential forms of biotechnology, some recent technologies, and the relevance of local stakeholder engagement and policy interventions for sustainable use. Future directions for research will emphasize good practices for extraction, pharmacological science, and ultimately ecological preservation.
- 16 October 2026
- Published by Taylor & Francis
- p. 197-213
Mangroves as a Source for Tannins
Mangroves are special coastal ecosystems that are very important sources of natural tannins, natural polyphenolic substances with pharmacological, industrial, or environmental applications. This review examines the diversity of mangrove species that produce tannins, the chemical structures and classification of tannins, and their applications. Mangrove tannins have potent antimicrobial, antioxidant, and anti-inflammatory properties, which may serve therapeutic uses and several biotechnological applications, including drug delivery systems and biodegradable materials. Industrial uses include leather tanning, dyeing, and preservation, reflecting their diverse commercial applications. Conservation and harvesting of mangrove resources need to be considered, as over-exploitation of these resources can have negative impacts on mangrove community health, biodiversity, and ecosystem services. This review will include traditional and modern harvesting practices, analyses and analytical technologies, and other variables that may influence the production and quality of tannins. The review will illustrate potential forms of biotechnology, some recent technologies, and the relevance of local stakeholder engagement and policy interventions for sustainable use. Future directions for research will emphasize good practices for extraction, pharmacological science, and ultimately ecological preservation.
- 14 October 2026
- Published by Springer Nature in Advances in Traditional Medicine
- Vol. 26  (4) , 893-904
Therapeutic potential of ayurvedic polyherbal Dhatryadi Yoga in estradiol valerate-induced PCOS in rats
- 14 October 2026
- Published by Springer Nature in Advances in Traditional Medicine
- Vol. 26  (4) , 893-904
Therapeutic potential of ayurvedic polyherbal Dhatryadi Yoga in estradiol valerate-induced PCOS in rats
- 28 September 2026
- Published by Bentham Science Publishers Ltd. in Drug Delivery Letters
- Vol. 16, 1-19
Auricular Route as a Next-Generation Gateway for Nanotherapeutic Delivery: Bioinspired Strategies for the Intervention of Neurodegenerative Disorders
Introduction: Alzheimer's Disease (AD) and Parkinson's Disease (PD) are progressive in nature and are classified as neurodegenerative diseases. Because treatments are often ineffective and drugs have limited ability to cross the blood-brain barrier (BBB), extensive research has explored the auricular route as a potentially less invasive way to deliver drugs to the CNS and modulate the nervous system locally. Currently, evidence is insufficient to support direct BBB bypass. Methods: This study is a narrative review of the evidence supporting the use of auricular therapies, including auricular vagus nerve stimulation (aVNS), localised delivery of drugs via the auricular region, and delivery of therapeutics to the auricular region using nano-carriers, in the treatment of AD and PD. The literature was reviewed for its mechanistic rationale and evidence supporting its use, as well as to identify translational barriers to treatment. Results: There is little current literature exploring the auricle for delivering treatments aimed at slowing down the progression of Neurodegenerative Disorders. There is evidence from preclinical and early-phase studies showing that treatments through the auricle may change neuroinflammatory signalling, regulate neurotransmitter activity, and provide controlled pharmacological delivery. Studies on aVNS suggest how it modulates autonomic and inflammatory pathways. Nanocarrier systems may facilitate improved localized pharmacological delivery, but current data supporting pharmacokinetics/biodistribution and clinical outcomes remain scarce. Conclusion: Auricular methods of treatment may offer a new method to reduce the invasiveness of treatment options that are given to reduce the progression of both AD and PD, but further mechanistic, translational, and clinical studies remain required to support efficacy.
- 28 September 2026
- Published by Bentham Science Publishers Ltd. in Drug Delivery Letters
- Vol. 16, 1-19
Auricular Route as a Next-Generation Gateway for Nanotherapeutic Delivery: Bioinspired Strategies for the Intervention of Neurodegenerative Disorders
Introduction: Alzheimer's Disease (AD) and Parkinson's Disease (PD) are progressive in nature and are classified as neurodegenerative diseases. Because treatments are often ineffective and drugs have limited ability to cross the blood-brain barrier (BBB), extensive research has explored the auricular route as a potentially less invasive way to deliver drugs to the CNS and modulate the nervous system locally. Currently, evidence is insufficient to support direct BBB bypass. Methods: This study is a narrative review of the evidence supporting the use of auricular therapies, including auricular vagus nerve stimulation (aVNS), localised delivery of drugs via the auricular region, and delivery of therapeutics to the auricular region using nano-carriers, in the treatment of AD and PD. The literature was reviewed for its mechanistic rationale and evidence supporting its use, as well as to identify translational barriers to treatment. Results: There is little current literature exploring the auricle for delivering treatments aimed at slowing down the progression of Neurodegenerative Disorders. There is evidence from preclinical and early-phase studies showing that treatments through the auricle may change neuroinflammatory signalling, regulate neurotransmitter activity, and provide controlled pharmacological delivery. Studies on aVNS suggest how it modulates autonomic and inflammatory pathways. Nanocarrier systems may facilitate improved localized pharmacological delivery, but current data supporting pharmacokinetics/biodistribution and clinical outcomes remain scarce. Conclusion: Auricular methods of treatment may offer a new method to reduce the invasiveness of treatment options that are given to reduce the progression of both AD and PD, but further mechanistic, translational, and clinical studies remain required to support efficacy.
- 6 September 2026
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 127
Targeting the tumor microenvironment in cancer immunotherapy: Emerging therapeutic targets and drug discovery strategies
- 6 September 2026
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 127
Targeting the tumor microenvironment in cancer immunotherapy: Emerging therapeutic targets and drug discovery strategies
- 12 August 2026
- Published by Elsevier in Ageing Research Reviews
- Vol. 121
Targeting the hallmarks of ageing: Pharmacological challenges and breakthroughs in CRISPR delivery systems and future prospects
- 12 August 2026
- Published by Elsevier in Ageing Research Reviews
- Vol. 121
Targeting the hallmarks of ageing: Pharmacological challenges and breakthroughs in CRISPR delivery systems and future prospects
- 7 August 2026
- Published by Elsevier in Pharmacological Research - Reports
- Vol. 6
Effective approaches for the management of polycystic ovary syndrome by using traditional Chinese medicine
- 7 August 2026
- Published by Elsevier in Pharmacological Research - Reports
- Vol. 6
Effective approaches for the management of polycystic ovary syndrome by using traditional Chinese medicine